Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
Sophia Lengsfeld(University of Basel), Bettina Winzeler(University Hospital of Basel), Tanja Vukajlovic(University Hospital of Basel), Cemile Bathelt(University of Basel), Brida Caviezel(University Hospital of Basel), D. Vogt(University of Basel), Laura Werlen(University Hospital of Basel), Leila Probst(University of Basel), Yara Emara(University Hospital of Basel), Manuel Fischer(University Hospital of Basel), Fabienne Baur(University Hospital of Basel)
Cited by 17
Related Papers
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
|The Lancet Respiratory Medicine|2023|124
Effects of dulaglutide on alcohol consumption during smoking cessation
|JCI Insight|2023|75
Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire: A randomized, double-blind, placebo-controlled crossover trial
|Endocrine Abstracts|2023|2
THU122 Effects Of A GLP-1 Agonist On Consumption Of Alcohol In Patients Treated For Smoking Cessation
|Journal of the Endocrine Society|2023|1